Xiao Peng
- Immunology top 2%
- Immunodeficiency and Autoimmune Disorders 6
- Immunotherapy and Immune Responses 3
- Cancer Research top 2%
- MicroRNA in disease regulation 8
- Molecular Biology top 5%
- DNA Repair Mechanisms 5
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
- Cell Biology top 5%
- Oncology top 10%
-
- Genomics and Rare Diseases 3
- Blood disorders and treatments 3
- Co-authors
- Alexander Y. RudenskySteven Z. JosefowiczAshutosh ChaudhryYe ZhengKatherine A. ForbushTodd R. GolubKang KangDeming Gou
- Partner nations
- United StatesChinaGermany
In The Last Decade
Xiao Peng
38 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Immunology 1.2k
- Cancer Research 749
- Molecular Biology 1.7k
- Cell Biology 248
- Oncology 360
Countries citing papers authored by Xiao Peng
This map shows the geographic impact of Xiao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Peng more than expected).
Fields of papers citing papers by Xiao Peng
This network shows the impact of papers produced by Xiao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Peng. The network helps show where Xiao Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiao Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 34 | |
| 10 | 2022 | 41 | |
| 11 | 2021 | 147 | |
| 12 | 2021 | 15 | |
| 13 | 2021 | 30 | |
| 14 | 2021 | 1 | |
| 15 | 2019 | 15 | |
| 16 | 2019 | 16 | |
| 17 | 2012 | 356 | |
| 18 | 2012 | 90 | |
| 19 | 2008 | 263 | |
| 20 | 2008 | 73 |
About Xiao Peng
Xiao Peng is a scholar working on Cancer Research, Immunology and Genetics, having authored 40 papers that have together received 3.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers), DNA Repair Mechanisms (5 papers), Circular RNAs in diseases (4 papers), Genomics and Rare Diseases (3 papers), Blood disorders and treatments (3 papers), Immunotherapy and Immune Responses (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Immunology (1.2k citations), Cancer Research (749 citations) and Molecular Biology (1.7k citations). Xiao Peng has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Alexander Y. Rudensky, Steven Z. Josefowicz, Ashutosh Chaudhry, Ye Zheng, Katherine A. Forbush, Todd R. Golub, Kang Kang, Deming Gou, Jinyan Du and Haley Hieronymus. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.